Share Price Information for Lombard Med.tec (LMT)

Price
190.00

Bid
188.00

Ask
192.00

Change
0.00%

0.00

Volume
4,421

Open
195.00

High
192.12

Low
188.80

Close
190.00

Currency
GBX
| Currency |
Issue Country |
Shares in Issue |
Market Capitalisation |
Market Size |
| GBX |
GB |
30.20m
|
£57.38m |
200 |
| 52 Week High |
245.00 |
52 Week High Date |
15-FEB-2013 |
| 52 Week Low |
100.00 |
52 Week Low Date |
10-OCT-2012 |
| # Trades |
Vol. Sold |
Vol. Bought |
PE Ratio |
Earnings |
Dividend |
Yield |
| 9 |
4,421 |
0 |
-4.623 |
-41.10 |
0.00 |
0.00 |
17-May-13
13:52:09
188.80
521
Sell*
188.00
192.00
983.65
O

Trade Type:
Ordinary
17-May-13
13:50:17
190.00
500
Sell*
190.00
195.00
950.00
O

Trade Type:
Ordinary
17-May-13
13:50:15
190.00
200
Sell*
190.00
195.00
380.00
O

Trade Type:
Ordinary
*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.
View more Lombard Med.tec trades >>| Directors Deals for Lombard Med.tec (LMT) |
| Trade Date | Action | Notifier | Price | Currency | Amount | Holding |
|---|
| 22-Mar-13 | Buy |  John Rush held the position of Non-Executive Chairman at Lombard Medical Technologies at the time of this trade. John Rush | 0 | | 4,000 | 12142 |
| 22-Mar-13 | Buy |  Peter Phillips held the position of Chief Technology Officer at Lombard Medical Technologies at the time of this trade. Peter Phillips | 0 | | 6,000 | 12214 |
| 22-Mar-13 | Buy |  Simon Hubbert held the position of CEO at Lombard Medical Technologies at the time of this trade. Simon Hubbert | 0 | | 4,000 | 7142 |
View more Lombard Med.tec directors dealings >>Date/Time
Author
Subject
Share Price†
Opinion
6 Mar '13
TC101
Observation
206.50
Hold
Lots of sells recently! Either profit taking or someone knows something we dont. Surprising as LMT have approval now. Need to be quick and start getting thoses sales teams rolling in the orders! Strike whilst the iron is hot! Unless takeover is on a few peoples mind. Need to watch this closely!
27 Feb '13
TC101
Edison Investment Research
215.50
Hold
Edison Investment Research values the shares at £3.46 since LMT got approval. I hope they are right!
25 Feb '13
TC101
Jange
213.00
Hold
Jange - Its great that you can cut and paste the RNS's .....but what are your opinions on the stock?? Well.....take over could happen so i think we need to keep an eye on that! Just need to see how they are going to penetrate the US marketing since approval was given!
24 Feb '13
jange
LMT
212.50
No Opinion
Business description Lombard Medical Technologies is a UK medical technology firm principally focused on the development and commercialisation of the Aorfix stent graft system which is approved in Europe and the US for the endovascular (minimally invasive) repair of abdominal aortic aneurysm (AAA).
24 Feb '13
jange
LMT
212.50
No Opinion
140p. Valuation: Increased to £104.7m from £97.7m We have increased our DCF valuation of Lombard from £97.7m to £104.7m or 346p/share (with a pro forma 30.3m shares in issue), having rolled forward our DCF by half a year. Our valuation previously included the expected US approval of Aorfix at the end of 2012. US launch is now expected in the second half of 2013. We will review our forecasts after the company’s full year results in March.
24 Feb '13
jange
LMT
212.50
No Opinion
Funded to go The fundraising will provide funds to support the US launch, gear up production and develop a next generation lower profile version of Aorfix. Lombard could also repay its £3m convertible loan with Invesco (owns 39% of shares) before 1 July 2013. Thereafter the loan is convertible to equity at the strike price of 140p.
†Share prices shown are taken at time of message posting.
Thread ViewView more share chat for Lombard Med.tec (LMT) >>Please
Login or
Register to post messages
Request your Free brochures on share dealing, spread betting and CFDs